Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Clinical Trial: Drug that Stops Myeloma Progression with Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

TGF-β, a multifunctional cytokine, is produced in multiple Myeloma cells and cells in the bone marrow environment and stimulates myeloma progression. A new drug called  TEW-797 targets this cytokine and kills myeloma cells alone and with other myeloma drugs. “Our data demonstrate that TEW-7197 effectively modulates the MM TME and is associated with a potent [...]



This post first appeared on Page Not Found - The Myeloma Crowd, please read the originial post: here

Share the post

Clinical Trial: Drug that Stops Myeloma Progression with Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

×

Subscribe to Page Not Found - The Myeloma Crowd

Get updates delivered right to your inbox!

Thank you for your subscription

×